Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07799675
Starting soon Not applicable

Telerehabilitation in Pulmonary Arterial Hypertension

NCT07799675 · tracked via the Priya Life Science Spain tracker
Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Phase
Not applicable
Started
2026-08-30
Last updated
2026-09-02

Condition(s) studied

Pulmonary Arterial Hypertension (PAH)

Investigational drug(s) / intervention(s)

Home-based telerehabilitation program

Home-based telerehabilitation program: An 8-week home-based telerehabilitation program delivered via a mobile application, consisting of three weekly 60-minute sessions combining respiratory physiotherapy, inspiratory muscle training, strength exercises, coordination, aerobic walking, and stretching. One session is live-supervised via videoconference and two are completed independently using pre-recorded modules.

Study summary

Context: Pulmonary arterial hypertension (PAH) causes severe exercise intolerance and reduced quality of life, while access to supervised rehabilitation remains limited.

Objective: Evaluate the safety, feasibility, and clinical effects of an 8-week structured home-based telerehabilitation program in stable PAH patients. Methods: A multicenter, prospective, single-arm study including 34 adults with Group 1 PAH (WHO functional class II-III) performing three weekly exercise sessions via a digital platform.

Outcomes: The primary endpoint is peak oxygen consumption (VO₂peak) via cardiopulmonary exercise testing, alongside 6-minute walk distance, quality of life questionnaires, inflammatory biomarkers, and safety tracking.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Confirmed diagnosis of stable pulmonary arterial hypertension (PAH). * Age 18 years or older. * Ability to use a smartphone or mobile application for the telerehabilitation program. * Signed informed consent. Exclusion Criteria: * Acute cardiorespiratory instability or medical contraindication to physical exercise. * Cognitive impairment or psychiatric disorders preventing comprehension or use of the telerehabilitation program. * Simultaneous participation in another interventional clinical trial.

Primary outcome measure(s)

  • Functional capacity determined by peak O2 consumption (VO2peak) — Comparison between baseline and the value obtained after 8 weeks of intervention.
    Evaluation of the intervention's efficacy through the increase in peak oxygen consumption during cardiopulmonary exercise testing (CPET/PECP).

Trial sites (1)

FacilityCityRegionStatus
FIMABIS Málaga Málaga

More Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud trials in Spain

Implementing Online Mental Health Program Starting soon
Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients Recruiting
NIMA-Colon Cancer Study Recruiting
Chronobiology and Home Parenteral Nutrition Study. CHRONO-HPN Study Recruiting
Chronobiology and Enteral Nutrition Recruiting

Other trials for the same condition

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) Recruiting
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07799675 on ClinicalTrials.gov ↗ ← All trials in Spain